W. Hildebrand

发表

The Length Distribution of Class I–Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele–Specific Binding Preference

M. Nielsen, Bjoern Peters, J. Sidney, 2016, The Journal of Immunology.

A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells

E. Mardis, G. Linette, V. Magrini, 2015, Science.

MHC-I Genotype Restricts the Oncogenic Mutational Landscape

T. Ideker, H. Carter, W. Hildebrand, 2017, Cell.

Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data.

Morten Nielsen, Bjoern Peters, Birkir Reynisson, 2020, Journal of proteome research.

Toward a Definition of Self: Proteomic Evaluation of the Class I Peptide Repertoire1

Muthuraman Sathiamurthy, William H. Hildebrand, Heather D. Hickman, 2004, The Journal of Immunology.

Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data

Morten Nielsen, Bjoern Peters, William H. Hildebrand, 2019, bioRxiv.

Discovering naturally processed antigenic determinants that confer protective T cell immunity.

Alessandro Sette, Sine R Hadrup, James E Crowe, 2013, The Journal of clinical investigation.

Direct Interrogation of Viral Peptides Presented by the Class I HLA of HIV-Infected T Cells

Christian Brander, Alex Olvera, Steven Cate, 2014, Journal of Virology.

Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens

Zachary L. Skidmore, E. Mardis, O. Griffith, 2019, Proceedings of the National Academy of Sciences.

HLA class I molecules reflect an altered host proteome after influenza virus infection.

Wilfried Bardet, W. Hildebrand, Angela Wahl, 2010, Human immunology.

A Kmer-based paired-end read (KPR) de novo assembler and genotyper to genotype major histocompatibility complex class I (MHC-I) alleles for the dog

Shaying Zhao, W. Hildebrand, S. Tompkins, 2020, bioRxiv.

Priming of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cell responses by dendritic cells loaded with HIV-1 proteins.

C. Rinaldo, Xiao-li Huang, W. Hildebrand, 2003, The Journal of infectious diseases.

HLA-B*35-PX and HLA-B*35-PY subtype differentiation does not predict observed differences in level of HIV control in a Peruvian MSM cohort.

À. Olvera, C. Brander, W. Hildebrand, 2014, AIDS.

A Charged Amino Acid Residue in the Transmembrane/Cytoplasmic Region of Tapasin Influences MHC Class I Assembly and Maturation1

A. Purcell, W. Hildebrand, J. L. Petersen, 2005, The Journal of Immunology.

Maturation Tapasin Influences MHC Class I Assembly Transmembrane / Cytoplasmic Region of A Charged Amino Acid Residue in the

A. Purcell, W. Hildebrand, J. L. Petersen, 2004 .

Defects in Antiviral T Cell Responses Inflicted by Aging-Associated miR-181a Deficiency

W. Hildebrand, A. Hirsch, C. Weyand, 2019, Cell reports.

Recognition of Lyso-Phospholipids by Human Natural Killer T Lymphocytes

E. Adams, G. Besra, W. Hildebrand, 2009, PLoS biology.

Transcriptionally Abundant Major Histocompatibility Complex Class I Alleles Are Fundamental to Nonhuman Primate Simian Immunodeficiency Virus-Specific CD8+ T Cell Responses

Melisa L. Budde, Jennifer J. Lhost, V. Brusic, 2011, Journal of Virology.

Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes

M. Loeb, C. Rinaldo, Curtis McMurtrey, 2008, Proceedings of the National Academy of Sciences.

The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles.

E. Adams, P. Parham, A. Little, 1994, Tissue antigens.

Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides

Zhihua Li, D. Margulies, W. Hildebrand, 2021, Frontiers in Immunology.

HLA-B67: a member of the HLA-B16 family that expresses the ME1 epitope.

P. Parham, A. Little, W. Hildebrand, 1994, Tissue antigens.

T Cell Mimicry and Epitope Specificity of Cross-Reactive T Cell Clones from Rheumatic Heart Disease1

W. Hildebrand, V. Fischetti, M. Cunningham, 2005, The Journal of Immunology.

HLA-B15: a widespread and diverse family of HLA-B alleles.

P. Parham, M. Bunce, W. Hildebrand, 1994, Tissue antigens.

The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27 (B*2708).

P. Parham, M. Bunce, W. Hildebrand, 1994, Tissue antigens.

The immune response under stress: the role of HSP-derived peptides.

W. Hildebrand, Heather D. Hickman-Miller, 2004, Trends in immunology.

The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands

K. Garcia, D. Bushnell, M. Nielsen, 2017, Cell Reports.

Present HLA-B-Like Peptides Rhesus Macaque MHC Class I Molecules

D. Watkins, Wilfried Bardet, W. Hildebrand, 2005 .

Single‐cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing

W. Hildebrand, A. Welm, T. Hode, 2022, Clinical and translational medicine.

C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells.

W. Hildebrand, H. Hickman, K. Prilliman, 2000, Human immunology.

Anchored at Their C Termini HLA-B15 Peptide Ligands Are Preferentially

Jihua Wang, W. Hildebrand, M. Lindsey, 1999 .

HLA-C Diversity Sequence-Based Typing Provides a New Look at

W. Hildebrand, M. Fernandez-Vina, H. Hickman, 1998 .

Sequence-based typing provides a new look at HLA-C diversity.

W. Hildebrand, M. Fernandez-Vina, H. Hickman, 1998, Journal of immunology.

Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing

D. Margulies, Curtis McMurtrey, W. Hildebrand, 2016, Proceedings of the National Academy of Sciences.

Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A1*02601 and Mamu-B*08301 reveals HLA-A2 and HLA-A3 supertypic specificities

Bjoern Peters, J. Sidney, A. Sette, 2011, Immunogenetics.

Non-conservative substitutions distinguish previously uncharacterized HLA-A molecules.

W. Hildebrand, H. Hickman, E. Trachtenberg, 2001, Tissue antigens.

Determination of Cellular Lipids Bound to Human CD1d Molecules

Wilfried Bardet, W. Hildebrand, J. Gumperz, 2009, PloS one.

Peptide-Binding Repertoires HLA-A*02 Have Overlapping Patr-AL and Polymorphic Human Chimpanzee Peptide Binding Site, Conserved Although Divergent in Residues of the

M. Ronaghi, E. Adams, K. Garcia, 2011 .

Although Divergent in Residues of the Peptide Binding Site, Conserved Chimpanzee Patr-AL and Polymorphic Human HLA-A*02 Have Overlapping Peptide-Binding Repertoires

M. Ronaghi, E. Adams, K. Garcia, 2011, The Journal of Immunology.

Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection

W. Hildebrand, Ryan S Simmons, D. Rockey, 2015, Infection and Immunity.

Nonhuman primate models to evaluate vaccine safety and immunogenicity.

R. Kennedy, W. Hildebrand, M. Shearer, 1997, Vaccine.

Differential MHC class I expression in distinct leukocyte subsets

Jennifer J. Lhost, K. Broman, Steven Wolinsky, 2011, BMC Immunology.

TCR-like Biomolecules Target Peptide/MHC Class I Complexes on the Surface of Infected and Cancerous Cells

W. Hildebrand, J. Weidanz, Oriana E. Hawkins, 2011, International reviews of immunology.

MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage

E. Adams, Curtis McMurtrey, W. Hildebrand, 2018, Science Immunology.

Nucleotide sequence analysis of H-2Df and the spontaneous in vivoH-2Dfm2 mutation

J. Martinko, R. Horton, L. Pease, 1992 .

Surface Phenotype and Functionality of WNV Specific T Cells Differ with Age and Disease Severity

M. Loeb, C. Rinaldo, Curtis McMurtrey, 2010, PloS one.

Antibodies to peptide–HLA complexes have potential application for cancer diagnosis and therapy

W. Hildebrand, J. Weidanz, 2011 .

Expanding the Targets Available to Therapeutic Antibodies via Novel Disease-specific Markers

W. Hildebrand, J. Weidanz, 2011, International reviews of immunology.

Riboflavin Metabolism Variation among Clinical Isolates of Streptococcus pneumoniae Results in Differential Activation of Mucosal‐associated Invariant T Cells

Curtis McMurtrey, W. Hildebrand, M. Kronenberg, 2018, American journal of respiratory cell and molecular biology.

Two subtypes of HLA-B51 differing by substitution at position 171 of the α2 helix

P. Parham, W. Hildebrand, T. Juji, 1992, Immunogenetics.

Molecular characterization of HLA-A*6803

W. Hildebrand, P. Terasaki, M. Lau, 1996, Immunogenetics.

Rheumatic Heart Disease Cross-Reactive T Cell Clones from T Cell Mimicry and Epitope Specificity of Fischetti and

W. Hildebrand, V. Fischetti, M. Cunningham, 2005 .

Peptides with Arginine at P2 Sequence Similarity to HLA-B27 that Binds an MHC Class I Molecule with Only Limited Gorillas with Spondyloarthropathies Express

Todd M. Allen, A. Sette, D. Watkins, 2001 .

Characterization of an HLA-A26 serologic variant

W. Hildebrand, J. Keller, M. Ellexson, 1998, Immunogenetics.

Description of a modified sequencing strategy and the molecular characterization of HLA-B*8201.

W. Hildebrand, P. Chrétien, L. Zhang, 1996, Tissue antigens.

Novel alleles HLA-B*7802 and B*51022: evidence for convergency in the HLA-B5 family.

W. Hildebrand, P. Terasaki, C. Hurley, 1996, Tissue antigens.

Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens.

W. Hildebrand, P. Terasaki, M. Lau, 1995, Human immunology.

The molecular basis for reactivity of anti-Cw1 and anti-Cw3 alloantisera with HLA-B46 haplotypes.

R. Williams, P. Parham, W. Hildebrand, 1992, Tissue antigens.

HLA-Bw22: a family of molecules with identity to HLA-B7 in the alpha 1-helix.

P. Parham, A. Little, J. Madrigal, 1992, Journal of immunology.

The presence of HLA-A*2403 and HLA-B*1512 on the same haplotype in a Thai family.

E. Adams, P. Parham, W. Hildebrand, 1996, Tissue antigens.

Structural heterogeneity in HLA-B70, a high-frequency antigen of black populations.

P. Parham, A. Little, W. Hildebrand, 1993, Tissue antigens.

Primary structure shows HLA-B59 to be a hybrid of HLA-B55 and HLA-B51, and not a subtype of HLA-B8.

P. Parham, W. Hildebrand, J. D. Domena, 1993, Tissue antigens.

Structural diversity in the HLA-A10 family of alleles: correlations with serology.

M. Petzl-Erler, A. Little, J. Madrigal, 1993, Tissue antigens.

NIAID workshop on Flavivirus immunity.

F. Ennis, E. Harris, W. Hildebrand, 2010, Viral immunology.

Anti-Human Immunodeﬁciency Virus Type 1 (HIV-1) CD8 1 T-Lymphocyte Reactivity during Combination Antiretroviral Therapy in HIV-1-Infected Patients with Advanced Immunodeﬁciency

J. Margolick, J. Mellors, C. Rinaldo, 2000 .

The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression

À. Olvera, C. Brander, W. Hildebrand, 2015, AIDS.

The Memory T Cell Response to West Nile Virus in Symptomatic Humans following Natural Infection Is Not Influenced by Age and Is Dominated by a Restricted Set of CD8+ T Cell Epitopes1

M. Drebot, M. Loeb, Curtis McMurtrey, 2008, The Journal of Immunology.

Cell Epitopes + and Is Dominated by a Restricted Set of CD 8 Natural Infection Is Not Influenced by Age Virus in Symptomatic Humans following The Memory T Cell Response to West Nile

M. Drebot, M. Loeb, Curtis McMurtrey, 2008 .

Polymorphism of human HLA-DRB1 antigens generated by genetic exchange between DR2 (DRB1*15011) and DR6 (DRB1*1405) alleles: a novel DRB1 allele (DRB1*1437) identified in a Paiwan tribe member of Taiwan.

W. Hildebrand, M. Tilanus, Y. Shiao, 2001, Tissue antigens.

A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules

J. Sidney, A. Sette, B. Mothé, 2012, Immunogenetics.

Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization.

Wilfried Bardet, W. Hildebrand, R. Buchli, 2004, Biochemistry.

Urinary Peptides As a Novel Source of T Cell Allergen Epitopes

S. Mallal, Bjoern Peters, J. Sidney, 2018, Front. Immunol..

Machine learning reveals limited contribution of trans-only encoded variants to the HLA-DQ immunopeptidome by accurate and comprehensive HLA-DQ antigen presentation prediction

M. Nielsen, B. Peters, W. Hildebrand, 2022, bioRxiv.

HLA alleles and haplotypes among the Lakota Sioux: report of the ASHI minority workshops, part III.

M. Fallin, A. Zachary, W. Hildebrand, 2004, Human immunology.

Elevated soluble HLA II protein levels in patients with alpha-1 antitrypsin deficiency with or without COPD

J. Gaughan, W. Hildebrand, R. Buchli, 2010, Experimental lung research.

HLA antigens, alleles and haplotypes among the Yup'ik Alaska natives: report of the ASHI Minority Workshops, Part II.

H. Erlich, M. Fallin, A. Zachary, 2002, Human immunology.

Peptide motif of the class I molecule HLA-B*1503

W. Hildebrand, M. Lindsey, K. Prilliman, 1999, Immunogenetics.

Direct quantitative measurement of the kinetics of HLA-specific antibody interactions with isolated HLA proteins.

F. Claas, Curtis McMurtrey, W. Hildebrand, 2017, Human immunology.

An HLA-Presented Fragment of Macrophage Migration Inhibitory Factor Is a Therapeutic Target for Invasive Breast Cancer

W. Hildebrand, S. Lightfoot, A. Rawat, 2011, The Journal of Immunology.

Target for Invasive Breast Cancer Migration Inhibitory Factor Is a Therapeutic An HLA-Presented Fragment of Macrophage

W. Hildebrand, A. Rawat, J. Weidanz, 2011 .

Subcellular location of source proteins improves prediction of neoantigens for immunotherapy

H. Carter, W. Hildebrand, Andrea Castro, 2022, The EMBO journal.

Localized ablative immunotherapy drives de novo CD8+ T-cell responses to poorly immunogenic tumors

W. Hildebrand, S. Kaabinejadian, A. Hoover, 2022, Journal for ImmunoTherapy of Cancer.

Single-Chain HLA-A2 MHC Trimers That Incorporate an Immundominant Peptide Elicit Protective T Cell Immunity against Lethal West Nile Virus Infection

M. Diamond, Curtis McMurtrey, W. Hildebrand, 2010, The Journal of Immunology.

T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells

Curtis McMurtrey, Wilfried Bardet, W. Hildebrand, 2017, PloS one.

Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells

E. Adams, Curtis McMurtrey, W. Hildebrand, 2022, bioRxiv.

Role of MAIT cells in pulmonary bacterial infection.

Curtis McMurtrey, W. Hildebrand, M. Kronenberg, 2018, Molecular immunology.

Sequence-based typing of HLA class I alleles in Alaskan Yupik Eskimo.

A. Zachary, W. Hildebrand, M. Fernandez-Vina, 2001, Human immunology.

Polymorphism at codons 114, 116, 145, and 163 muddle the typing of HLA-B*1304.

W. Hildebrand, P. Terasaki, M. Lau, 1997, Human immunology.

Characterization of baboon class I major histocompatibility molecules. Implications for baboon-to-human xenotransplantation.

R. Kennedy, W. Hildebrand, D. Cooper, 1996, Transplantation.

Distinctive HLA-A,B antigens of black populations formed by interallelic conversion.

M. Petzl-Erler, A. Little, J. Madrigal, 1992, Journal of immunology.

Machine learning reveals limited contribution of trans-only encoded variants to the HLA-DQ immunopeptidome

M. Nielsen, B. Peters, W. Hildebrand, 2023, bioRxiv.

Viral infection causes a shift in the self peptide repertoire presented by human MHC class I molecules

Jelena S. Bezbradica, C. Spencer, A. Link, 2015, Proteomics. Clinical applications.

glycoprotein B homolog of human herpesvirus 8 restricted CD8+T-cell epitope for the - Identification of an HLA ?A*0201

C. Rinaldo, Xiao-li Huang, W. Hildebrand, 2013 .

Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8.

C. Rinaldo, Xiao-li Huang, W. Hildebrand, 2002, Blood.

T cells of Parkinson’s disease patients recognize α–synuclein peptides

S. Mallal, L. Cote, Bjoern Peters, 2017, Nature.

Unusual HLA-B alleles in two tribes of Brazilian Indians

M. Petzl-Erler, P. Parham, J. Madrigal, 1992, Nature.

The Human Proteome Organization Chromosome 6 Consortium: integrating chromosome-centric and biology/disease driven strategies.

L. Foster, T. A. Binkowski, C. Borchers, 2014, Journal of proteomics.

Profiling antibodies to class II HLA in transplant patient sera.

Curtis McMurtrey, Wilfried Bardet, W. Hildebrand, 2014, Human immunology.

ScRNA-seq reveals tumor microenvironment remodeling induced by local intervention-based immunotherapy

Wei R. Chen, W. Hildebrand, A. Welm, 2020, bioRxiv.

Antigen presentation and interferon signatures in B cells driven by localized ablative cancer immunotherapy correlate with extended survival

Wei R. Chen, W. Hildebrand, Kaili Liu, 2022, Theranostics.

Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome

M. Nielsen, W. Hildebrand, C. Barra, 2021, bioRxiv.

Amyloid precursor-like protein 2 association with HLA class I molecules

N. Naslavsky, S. Caplan, W. Hildebrand, 2009, Cancer Immunology, Immunotherapy.

Unconventional Peptide Presentation by Major Histocompatibility Complex (MHC) Class I Allele HLA-A*02:01

M. Nielsen, Bjoern Peters, Curtis McMurtrey, 2017, The Journal of Biological Chemistry.

Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove

Morten Nielsen, Bjoern Peters, Alessandro Sette, 2016, eLife.

Class I MHC Expression in the Yellow Baboon1 2

W. Hildebrand, D. Sidebottom, R. Kennedy, 2001, The Journal of Immunology.

A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs.

A. Begovich, W. Hildebrand, S. Spellman, 2007, Human immunology.

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Harriet Noreen, Carolyn Hurley, Marcelo Fernandez-Vina, 2004, Blood.

Two MHC Class I Molecules Associated with Elite Control of Immunodeficiency Virus Replication, Mamu-B*08 and HLA-B*2705, Bind Peptides with Sequence Similarity12

John Sidney, Alessandro Sette, Nancy A. Wilson, 2009, The Journal of Immunology.

Definition of the viral targets of protective HIV-1-specific T cell responses

Todd M. Allen, D. Heckerman, B. Walker, 2011, Journal of Translational Medicine.

Mutually Exclusive T-Cell Receptor Induction and Differential Susceptibility to Human Immunodeficiency Virus Type 1 Mutational Escape Associated with a Two-Amino-Acid Difference between HLA Class I Subtypes

Todd M. Allen, E. Rosenberg, F. Pereyra, 2006, Journal of Virology.

Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activity.

W. Hildebrand, R. Buchli, R. Vangundy, 2010, World journal of gastroenterology.

Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery.

Wilfried Bardet, W. Hildebrand, R. Buchli, 2005, Biochemistry.

HLA‐B polymorphism affects interactions with multiple endoplasmic reticulum proteins

C. Lutz, W. Hildebrand, H. Turnquist, 2000, European journal of immunology.

Rhesus Macaque MHC Class I Molecules Present HLA-B-Like Peptides1

D. Watkins, Wilfried Bardet, W. Hildebrand, 2005, The Journal of Immunology.

Abacavir induces loading of novel self-peptides into HLA-B*57: 01 an autoimmune model for HLA-associated drug hypersensitivity

D. Margulies, Curtis McMurtrey, W. Hildebrand, 2012, AIDS.

Relative Dominance of Gag p24-Specific Cytotoxic T Lymphocytes Is Associated with Human Immunodeficiency Virus Control

Bette T. Korber, Christian Brander, Todd M. Allen, 2006, Journal of Virology.

Lymphocyte Responses to SIV T + Not Appear to Be Involved in CD8 MHC Class I Molecule, Mamu-B*01, Does The High Frequency Indian Rhesus Macaque

J. Sidney, D. O’Connor, Wilfried Bardet, 2017 .

The role of MHC class I allele Mamu-A*07 during SIVmac239 infection

J. Sidney, A. Sette, D. Watkins, 2011, Immunogenetics.

The High Frequency Indian Rhesus Macaque MHC Class I Molecule, Mamu-B*01, Does Not Appear to Be Involved in CD8+ T Lymphocyte Responses to SIVmac2391

Bjoern Peters, J. Sidney, A. Sette, 2005, The Journal of Immunology.

SIV T + Not Appear to Be Involved in CD 8 MHC Class I Molecule , Mamu-B * 01 , Does The High Frequency Indian Rhesus Macaque

Bjoern Peters, J. Sidney, A. Sette, 2005 .

Escape in One of Two Cytotoxic T-Lymphocyte Epitopes Bound by a High-Frequency Major Histocompatibility Complex Class I Molecule, Mamu-A*02: a Paradigm for Virus Evolution and Persistence?

Todd M. Allen, A. Hughes, J. Sidney, 2002, Journal of Virology.

A Novel Immunodominant CD8+ T Cell Response Restricted by a Common HLA-C Allele Targets a Conserved Region of Gag HIV-1 Clade CRF01_AE Infected Thais

Praphan Phanuphak, Christian Brander, Todd M. Allen, 2011, PloS one.

Mauritian Cynomolgus Macaques Share Two Exceptionally Common Major Histocompatibility Complex Class I Alleles That Restrict Simian Immunodeficiency Virus-Specific CD8+ T Cells

Jennifer J. Lhost, D. O’Connor, Wilfried Bardet, 2009, Journal of Virology.

T-Cell Tolerance for Variability in an HLA Class I-Presented Influenza A Virus Epitope

D. Fremont, Wilfried Bardet, W. Hildebrand, 2009, Journal of Virology.

HLA class I molecules consistently present internal influenza epitopes

G. Air, Wilfried Bardet, W. Hildebrand, 2009, Proceedings of the National Academy of Sciences.

Molecular definition of a polymorphic antigen (LA45) of free HLA-A and - B heavy chains found on the surfaces of activated B and T cells

P. Parham, A. Little, J. Madrigal, 1991, The Journal of experimental medicine.

Dengue virus‐infected human dendritic cells reveal hierarchies of naturally expressed novel NS3 CD8 T cell epitopes

C. Rinaldo, W. Hildebrand, P. Piazza, 2014, Clinical and experimental immunology.

HLA-B15 peptide ligands are preferentially anchored at their C termini.

W. Hildebrand, M. Lindsey, K. Prilliman, 1999, Journal of immunology.

A sixth family of HLA-A alleles defined by HLA-A*8001.

P. Parham, W. Hildebrand, W. Bias, 1993, Tissue antigens.

Cutting Edge: Class I Presentation of Host Peptides Following HIV Infection1

R. Kennedy, Wilfried Bardet, W. Hildebrand, 2003, The Journal of Immunology.

Erratum: T cells from patients with Parkinson’s disease recognize α-synuclein peptides

S. Mallal, L. Cote, Bjoern Peters, 2017, Nature.

T cells of Parkinson’s disease patients recognize α–synuclein peptides

S. Mallal, L. Cote, Bjoern Peters, 2017, Nature.

Population of the HLA ligand database.

M. Sathiamurthy, W. Hildebrand, H. Hickman, 2003, Tissue antigens.

Gorillas with Spondyloarthropathies Express an MHC Class I Molecule with Only Limited Sequence Similarity to HLA-B27 that Binds Peptides with Arginine at P21

Todd M. Allen, A. Sette, D. Watkins, 2001, The Journal of Immunology.

Association of HLA alleles with Plasmodium falciparum severity in Malian children

O. Doumbo, W. Hildebrand, C. Plowe, 2011, Tissue antigens.

Motif Inference Reveals Optimal CTL Epitopes Presented by HLA Class I Alleles Highly Prevalent in Southern Africa1

B. Walker, C. Brander, P. Goulder, 2006, The Journal of Immunology.

Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors

Vincent J. Lynch, Karlynn E. Neu, Charles L. Dulberger, 2017, Immunity.

Heterozygosity or homozygosity for 2 HLA class II haplotypes predict favorable outcomes for renal cell carcinoma treated with cytokine therapy.

W. Hildebrand, E. Grimm, J. Ellerhorst, 2003, The Journal of urology.

Serologic cross-reactivities poorly reflect allelic relationships in the HLA-B12 and HLA-B21 groups. Dominant epitopes of the alpha 2 helix.

P. Parham, J. Madrigal, W. Hildebrand, 1992, Journal of immunology.

Anti-Human Immunodeficiency Virus Type 1 (HIV-1) CD8+ T-Lymphocyte Reactivity during Combination Antiretroviral Therapy in HIV-1-Infected Patients with Advanced Immunodeficiency

J. Margolick, J. Mellors, C. Rinaldo, 2000, Journal of Virology.

Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry

Mark Cobbold, Jennifer G Abelin, Jennifer G. Abelin, 2015, Nature Protocols.

Determinants governing T cell receptor α/β-chain pairing in repertoire formation of identical twins

Russell E. Durrett, George Georgiou, Jonathan R. McDaniel, 2019, Proceedings of the National Academy of Sciences.

Critical factors in the development of fluorescence polarization-based peptide binding assays: an equilibrium study monitoring specific peptide binding to soluble HLA-A*0201.

W. Hildebrand, R. Buchli, R. Vangundy, 2006, Journal of immunological methods.

PREDmafa: a system for prediction of peptide binding to several MHC class I molecules in cynomolgus macaques

Vladimir Brusic, Guanglan Zhang, David H. O'Connor, 2011, BCB '11.

Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells

W. Hildebrand, J. Weidanz, A. Wahl, 2006, Expert review of proteomics.

Identification of Class I HLA T Cell Control Epitopes for West Nile Virus

William H. Hildebrand, C. Rinaldo, Curtis McMurtrey, 2013, PloS one.

Variability in German Cockroach Extract Composition Greatly Impacts T Cell Potency in Cockroach-Allergic Donors

Bjoern Peters, A. Sette, L. Bacharier, 2018, Front. Immunol..

The Immune Response Under Stress: Class I HLA Presentation of Host-Derived Peptides

Curtis McMurtrey, W. Hildebrand, J. Weidanz, 2007 .

Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties

W. Hildebrand, J. Weidanz, F. Neethling, 2010, Cancer Immunology, Immunotherapy.

A shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules

J. Sidney, A. Sette, B. Mothé, 2012, Immunogenetics.

Complexity among constituents of the HLA-B*1501 peptide motif

Mark Lindsey, Ron Bonner, W. Hildebrand, 1998, Immunogenetics.

Identification of breast cancer peptide epitopes presented by HLA-A*0201.

Wilfried Bardet, W. Hildebrand, J. Weidanz, 2008, Journal of proteome research.

Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501

Mark Lindsey, Ying Zhang, W. Hildebrand, 1997, Immunogenetics.

Processing and Presentation of Exogenous HLA Class I Peptides by Dendritic Cells from Human Immunodeficiency Virus Type 1-Infected Persons

C. Rinaldo, Xiao-li Huang, W. Hildebrand, 2005, Journal of Virology.

Evaluation of the Class I Peptide Repertoire Toward a Definition of Self: Proteomic

M. Sathiamurthy, W. Hildebrand, H. Hickman, 2004 .

Precision mouse models with expanded tropism for human pathogens

Isabel G. Newsome, R. Baric, W. Hildebrand, 2019, Nature Biotechnology.

Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late

M. Diamond, Curtis McMurtrey, Wilfried Bardet, 2016, The Journal of Immunology.

Proteome Sampling by the HLA Class I Antigen Processing Pathway

Ilka Hoof, Can Kesmir, William H. Hildebrand, 2012, PLoS Comput. Biol..

Levels of Specific Peptide-HLA Class I Complex Predicts Tumor Cell Susceptibility to CTL Killing1

W. Hildebrand, J. Weidanz, M. Chiriva-Internati, 2006, The Journal of Immunology.

A Kmer-based paired-end read de novo assembler and genotyper for canine MHC class I genotyping

Shaying Zhao, W. Hildebrand, S. Tompkins, 2023, iScience.

Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor

W. Hildebrand, S. Cate, J. Solheim, 2022, Immunologic Research.

Mutation at amino acid position 133 of H-2Dd prevents beta 2m association and immune recognition but not surface expression.

J. Martinko, W. Hildebrand, J. Connolly, 1991, Journal of immunology.

New DR5 sequences: a novel DRB1*11122 allele identified in Paiwan tribe members of Taiwan and a corrected sequence for the DRB1*1201 allele.

W. Hildebrand, Y. Shiao, S. Wu, 2001, Tissue antigens.

Human Herpesvirus 7 U21 Tetramerizes To Associate with Class I Major Histocompatibility Complex Molecules

W. Hildebrand, Qiuhong Wang, P. Schuck, 2014, Journal of Virology.

Human Leukocyte Antigen–Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer

Curtis McMurtrey, Wilfried Bardet, W. Hildebrand, 2015, Molecular Cancer Therapeutics.

A novel T‐cell receptor mimic defines dendritic cells that present an immunodominant West Nile virus epitope in mice

M. Diamond, M. Bevan, W. Hildebrand, 2014, European journal of immunology.

MR1 Restricted Mucosal-Associated Invariant T (MAIT) Cells Respond to Mycobacterial Vaccination and Infection in Nonhuman Primates

Thurston H. Y. Dang, E. Adams, L. Picker, 2016, Mucosal Immunology.

A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer

Wei R. Chen, Curtis McMurtrey, W. Hildebrand, 2019, Oncoimmunology.

NetH2pan: A Computational Tool to Guide MHC Peptide Prediction on Murine Tumors

Morten Nielsen, Massimo Andreatta, William H. Hildebrand, 2018, Cancer Immunology Research.

Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes.

C. Rinaldo, W. Hildebrand, P. Piazza, 2007, Journal of immunological methods.

Alpha-2 domain polymorphism and HLA class I peptide loading.

W. Hildebrand, H. Hickman, K. Prilliman, 1999, Tissue antigens.

Impact of HLA‐DRB1 allele polymorphisms on control of HIV infection in a Peruvian MSM cohort

À. Olvera, C. Brander, W. Hildebrand, 2017, HLA.

Breaking confinement: unconventional peptide presentation by major histocompatibility (MHC) class I allele HLA-A*02:01

M. Nielsen, B. Peters, Curtis McMurtrey, 2017 .

Delivery of loaded MR1 monomer results in efficient ligand exchange to host MR1 and subsequent MR1T cell activation

E. Adams, Andrew J. Olive, W. Hildebrand, 2023, bioRxiv.

Precision mouse models with expanded tropism for human pathogens

Isabel G. Newsome, R. Baric, W. Hildebrand, 2019, Nature Biotechnology.

Disparate binding of chaperone proteins by HLA-A subtypes

Erin L. Schenk, W. Hildebrand, H. Turnquist, 2002, Immunogenetics.

Erratum: T cells from patients with Parkinson’s disease recognize α-synuclein peptides

S. Mallal, L. Cote, Bjoern Peters, 2017, Nature.

Lethal West Nile Virus Infection Elicit Protective T Cell Immunity against Incorporate an Immundominant Peptide Single-Chain HLA-A2 MHC Trimers That

Curtis McMurtrey, W. Hildebrand, W. Gillanders, 2010 .

Human Herpesvirus 7 U21 Tetramerizes To Associate with Class I Major Histocompatibility Complex Molecules

W. Hildebrand, Qiuhong Wang, P. Schuck, 2014, Journal of Virology.

Mauritian Cynomolgus Macaques Share Two Exceptionally Common Major Histocompatibility Complex Class I Alleles That Restrict Simian Immunodeficiency Virus-Specific CD8+ T Cells

Jennifer J. Lhost, D. O’Connor, Wilfried Bardet, 2009, Journal of Virology.

Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences.

J. Martinko, R. Horton, L. Pease, 1990, Journal of immunology.

Elevated soluble HLA II protein levels in patients with alpha-1 antitrypsin deficiency with or without COPD

J. Gaughan, W. Hildebrand, R. Buchli, 2012, Experimental lung research.

HIV-Infected T Cells Presented by the Class I HLA of Direct Interrogation of Viral Peptides

À. Olvera, C. Brander, M. Plana, 2014 .

T-cell mimicry of streptococcal M protein and cardiac myosin epitopes by T-cell clones from rheumatic heart disease

W. Hildebrand, V. Fischetti, M. Cunningham, 2006 .

HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction.

Erin L. Schenk, W. Hildebrand, H. Turnquist, 2002, Human immunology.

Immune response in Parkinson’s disease driven by HLA display of α-synuclein peptides

S. Mallal, L. Cote, Bjoern Peters, 2017, The Journal of Immunology.

Human Leukocyte Antigen–Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer

Curtis McMurtrey, Wilfried Bardet, W. Hildebrand, 2015, Molecular Cancer Therapeutics.